Article info
Multiple sclerosis
Research paper
Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosis
- Correspondence to John J Moore, Department of Haematology, St. Vincent’s Hospital, Darlinghurst, NSW 2010, Australia; jmoore{at}stvincents.com.au
Citation
Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosis
Publication history
- Received October 10, 2018
- Revised August 13, 2018
- Accepted November 5, 2018
- First published December 11, 2018.
Online issue publication
January 13, 2023
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.